Latest Breaking News On - Ajinomoto north america holdings - Page 1 : vimarsana.com

Ajinomoto’s Forge Biologics acquisition brings contract development and manufacturing organization capabilities in gene therapy. Forge specializes in manufacturing AAV vectors used to deliver these therapies.

Yasuyuki otakeBio pharma servicesAjinomoto bio pharma services departmentAjinomoto north america holdingsForge biologicsBio pharma services departmentAjinomoto north americaMaryland based vector biomedWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciencesRock health